Get started
UNITEDHEALTH GROUPUNITEDHEALTH GROUPUNITEDHEALTH GROUP

UNITEDHEALTH GROUP

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4UNH trade ideas

UNH watch $288-297: Double Golden zone a serious Long Term Buy?UNH keeps getting bad news but may have bottomed. Wave may have tested Double Golden fibs successfully. Looking for some consolidation then launch of recovery. $287.91-296.92 (Gold) is the key zone of interest. $382.05-384.18 (Red) is the first long term target. $251.94-255.83 (Green) is the MUST_HOLD bottom. . Previous Analysis that caught the top EXACTLY Follow and Boost to encourage more such PRECISE charts. ================================================== .
NYSE:UNH
by EuroMotif
4
UNH Long Setup – Oversold Reversal PlayUnitedHealth ( NYSE:UNH ) is showing early signs of a potential bounce after a brutal selloff. 🔹 Price broke above the baseline (Ichimoku), first green candle close with bullish momentum 🔹 Williams %R showing oversold bounce from -80 levels 🔹 MACD turning positive on multiple timeframes 🔹 Clean risk/reward setup: ‣ Entry: $293 ‣ Target: $455 (55% upside) ‣ Stop: $249 (15% risk) ‣ R/R Ratio: 3.5+ This could be a high-reward reversal play if market strength continues. Watching closely for follow-through confirmation. #UNH #stocks #longsetup #tradingview #healthcare #swingtrade #technicalanalysis #chartsetup #Ichimoku
NYSE:UNHLong
by aaronkaltman
1
Generational Buy - Congratulations Well done to those that bought the dip on this below $300. I filled 80% of my position at $250 - the Point of Control according to the highest volume node. We had a capitulation in the top healthcare insurer. Absolute peak fear given the long list of events which culminated in the CEO leaving. His departure could have been the final flush out as holders capitulated. This presented a unique opportunity to get in on an undervalued stock trading at a P/E of 11.1. I’m a trader, so I won’t comment on the ethics of this company, it’s beyond the scope of my work. Technically I expect this relief rally to continue but in a corrective fashion with a potential resistance level looming. The 5th wave ending is normally followed by an abc correction, wave A has concluded, wave B is in play so I expect onward bullish recovery. For confluence, the weekly RSI had a complete reset hitting level of 30, the most oversold in many years. My indicator has flashed green (buy) so $250 could have been a generational low. None of this is financial advice, I got in at a good entry and I have a stop loss in place if this poops the bed again.
NYSE:UNHLong
by NoFOMO_
- UNH Down 38.2%—Are Buyers Ready to Step In?- "Healthcare Stocks at Higher Timeframe Support (Golden Ratio) —Bounce Incoming?" Key Reasons for UNH’s Stock Decline ✅ CEO Resignation → Andrew Witty stepped down for personal reasons, and former CEO Stephen Hemsley returned to stabilize the company. ✅ Suspended 2025 Outlook → UNH withdrew its financial guidance, citing higher-than-expected medical costs from new Medicare Advantage members. ✅ Regulatory Scrutiny → The DOJ is investigating UNH for possible Medicare fraud, adding uncertainty. ✅ Cybersecurity Breach → A massive data breach at its subsidiary Change Healthcare affected 190 million records, disrupting operations. ✅ Stock Market Reaction → UNH shares plummeted 16% in a single day, marking their lowest level in nearly five years. 🔹 Future Outlook Despite setbacks, UNH remains a dominant player in healthcare, with over 50 million insured members. Analysts believe the company can recover under Hemsley’s leadership, but short-term volatility remains high. United Health Group (UNH) trading at 250$ 0.618 F5 Support ( Golden Ratio ) Anticipating buyers to come in at this level. XLV. The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund (ETF) that tracks the healthcare sector within the S&P 500. It includes companies from pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. This sector is trading near Weekly Support Nodes Weekly OP + Weekly F3 nodes or Weekly OP F3 Agreement Its also Oversold. ELV - Elevance Health Inc, one of the main competitors to UNH in this space trading at Weekly F3 Support ( 0.382 retracement ) + Weekly Oversold Given UNH, ELV and the broader sector, XLV, are all trading at important Higher Timeframe Support nodes... with UNH down 20% today at one point, and down 38.2% from its highs ( largely within a month ) Looking for a Technical Bounce against Higher Timeframe Support nodes, on UNH, and the sector. "Will we see a bounce at these levels? Drop your thoughts below!" - Joseph AuXano #UNH #XLV #HealthcareStocks #TradingView
NYSE:UNHLong
by JosephAuxano
3
Not All Hype = Opportunity | UnitedHealth $UNH Analysis Lately, I’ve been seeing a lot of chatter about buying NYSE:UNH — UnitedHealth Group — as if it’s the “big opportunity” after the drop… But let’s keep it real — the chart isn’t confirming that yet. 👀 Take a close look 👇 Price completely broke structure from previous highs around $630. The recent drop was aggressive, and there's no clean retest or setup forming yet. Unlike NASDAQ:MSTR (MicroStrategy), which gave us a structured pullback and liquidity sweep, NYSE:UNH still looks like it has more downside to go. ⚠️ I’m not rushing in because the news or a rumor says “buy now.” I’d rather wait for a clearer structure, a lower low, and a reaction from a real demand zone — just like the example I marked on MicroStrategy. This is a great reminder: Let price tell you when it's time — not social media hype. For now, NYSE:UNH goes on the watchlist, not the buy list. 📉🧠
NYSE:UNHShort
by MoNi_MoN
UnitedHealth (UNH) Share Price ReboundsUnitedHealth (UNH) Share Price Rebounds A month ago, in our analysis of the UNH chart, we: → highlighted that UnitedHealth shares had lost nearly 23% in value; → drew a descending channel and suggested that bearish pressure could continue, threatening the support level around $450, which had held since early 2022. Since then, UNH’s stock price decisively broke below that level (as marked by the arrow), falling to around $250 — its lowest point since spring 2020 — before staging a sharp rebound. This steep price movement was driven by a series of fundamental developments, including: → the resignation of the CEO and news of a Department of Justice investigation into potential Medicare fraud; → UnitedHealth withdrawing its earnings guidance for the coming year; → political debates over the Medicaid programme as part of the 2025 budget negotiations; → President Trump’s directive to cut prescription drug prices. Recent news that the new CEO and several top executives have bought tens of millions of dollars’ worth of UNH shares appears to have renewed investor confidence — the share price rose above the $300 mark yesterday. Technical Analysis of UNH Share Chart These latest developments justify an update to the descending channel configuration. Of particular note is the gradual decline with limited volatility — a sign that the price is moving along the channel's median line (highlighted on the chart). In this setup: → the bounce from the $250 level points to the lower boundary of the channel; → traders may consider a scenario where the current recovery pushes UnitedHealth stock towards the median, after which supply pressure may return and offset the recent dominance of demand. It’s also possible that the key psychological level of $300 could now act as support. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
Life Time Opportunity Trade Setup NYSE:UNH Entry Price: $280 (at market open) Profit Target: $400 Stop Loss: $250 Risk-Reward Ratio: 4.3:1 Position Size: 1% of portfolio Why Bullish? UNH is trading near a 5-year low ($248.88) after a -50% drop in a month, driven by a DOJ Medicare fraud probe and CEO change. Despite the noise, analysts are bullish with 55 Buy ratings and a $445-$460 target, pointing to undervaluation (forward P/E ~10x). Institutional buying (Viking Global +12.5% stake) and a low VIX (17.83) support a potential rebound. Key Catalysts Technicals: Near 52-week low, RSI oversold, potential reversal. Fundamentals: $400B revenue, 15% EPS growth projected long-term. News: DOJ probe and suspended 2025 guidance weigh, but analysts see overreaction. Macro: VIX at 17.83 (stable), 10-year yields at 4.424% (headwind). Risks Ongoing DOJ investigation could escalate. Rising medical costs and volatile sentiment. Further downside if support at $250 breaks. Chart Notes UNH testing major support at $250-$270. Volume spikes on selling, but capitulation may signal a bottom. Watch for a break above $300 to confirm bullish momentum. Keep your long term vision Follow for the Best AI generated Signals on the market Ash.
NYSE:UNHLong
by AlphaSignals_ai
12
UNH | Catching the Fall Risky Play💊 Oversold Swing Play ⚠️ Risk Factor You're not trading a bounce—you’re stepping into a fire. Legal risk + uncertainty = extreme volatility. However, if markets stabilize, UNH could deliver a powerful mean-reversion move. UnitedHealth ( NYSE:UNH ) is trading in panic territory after: DOJ launched a criminal probe tied to Medicare Advantage billing Abrupt CEO resignation Suspended 2025 financial guidance, sparking investor selloff Still, the fundamentals aren’t dead. Q1 revenue is strong, and long-term value is on the table. 🎯 Trade Plan 🟢 Entry Zones 🔹 Zone 1: $275–$285 → Technical support + RSI oversold 🔹 Zone 2: $255 → 2021 breakout retest 🔹 Zone 3: $225 → Ultimate fear zone (deep capitulation possible) 💰 Profit Targets ✅ TP1: $300 – Psychological level & minor resistance ✅ TP2: $340 – Gap-fill area & 50-day MA ✅ TP3: $385+ – Long-term value zone if sentiment reverses 📌 Final Word UNH is no penny stock—it’s a $280B giant under siege. If you believe fear is overdone, this is a calculated shot at a rebound. Just keep your stops tight and your thesis tighter. 🚨 Disclaimer: This is not financial advice. Trading involves risk. Always DYOR and manage your exposure carefully.
NYSE:UNHLong
by Robert_V12
2
$UNH: With stock down more than 60%, is it in buy zone? NYSE:UNH with one after bad news lost 60% of its market cap from its ATH of 600$. NYSE:UNH the largest insurer in US has been in news for all the wrong reasons. The stock after losing 60% of the value has a dividend yield of 3.1% which is 2.5 times of the S&P Yield. The historical dividend growth of NYSE:UNH has been more than 8%. This makes NYSE:UNH a compelling story stock during the recent downturn. With recent insider buys of the NYSE:UNH stock most of the fundamental indicators indicate a positive outlook. But what are the technical indicators telling us? Today we are looking at the historical chart of the stock. The last time the stock was down more than 60% was during the 2007-2008 Financial recession. In 2008 it did lose more than 64%. If we investigate the long term RSI then we see it below 25 which we also saw last during the Financial recession. Verdict : Buy 1/3 @ 250, Buy 1/3 @ 275, Buy 1/3 now.
NYSE:UNHLong
by RabishankarBiswal
1